This inventor holds 1 USPTO granted patent. Top assignee: Fochon Biosciences, Ltd.. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Hong Fu - Innovator in TRK Kinase Inhibitors
Introduction
Hong Fu is a prominent inventor based in Chongqing, China. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of TRK kinase inhibitors. His innovative work has the potential to impact the treatment of various diseases.
Latest Patents
Hong Fu holds a patent for "Macrocyclic compounds as TRK kinases inhibitors." This patent includes certain TRK inhibitors, pharmaceutical compositions thereof, and methods of use thereof. His research in this area showcases his commitment to advancing medical science.
Career Highlights
Hong Fu is associated with Fochon Biosciences, Ltd., where he applies his expertise in drug development. His work at the company has positioned him as a key player in the pharmaceutical industry, contributing to the advancement of innovative therapies.
Collaborations
Hong Fu collaborates with talented individuals such as Qihong Liu and Chengxi He. These partnerships enhance the research and development efforts at Fochon Biosciences, leading to groundbreaking discoveries.
Conclusion
Hong Fu's contributions to the field of TRK kinase inhibitors exemplify his dedication to innovation in pharmaceuticals. His work not only advances scientific knowledge but also holds promise for future medical applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile